Info

Halozyme Therapeutics, Inc. (Halozyme) is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix (Matrix) for the drug delivery, oncology, and dermatology markets. Its portfolio of products is based on the property covering the family of human enzymes known as hyaluronidases. Halozyme has two United States Food and Drug Administration (FDA)-approved products, Cumulase, a product used for in vitro fertilization (IVF), and Hylenex, an agent for drug and fluid infusion.